🔎 Trials Near Me

Utama › Kanser (semua jenis) › Florida › Orlando

Kajian klinikal Kanser (semua jenis) di Orlando, FL

24 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Orlando (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Registry Study for Radiation Therapy Outcomes

Mengambil pesertaKajian pemerhatian
  • Orlando Health Cancer Institute, Orlando
Semua umur · Semua jantina · Dikemas kini 29 Sep 2026 · NCT01255748

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • GSK Investigational Site, Reunion · 23 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07277270

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

Mengambil pesertaFasa 3
  • Advent Health, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07195591

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Orlando Health Cancer Institute /ID# 280418, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07365241

Visugromab in Cachexia International Trial

Mengambil pesertaFasa 2/3
  • Clermont Oncology Center, Clermont · 24 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07112196

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Orlando Health Cancer Institute, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

Mengambil pesertaFasa 2
  • Clermont Oncology Center ( Site 0041), Clermont · 24 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07252739

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Mengambil pesertaFasa 3
  • Advent Health - Orlando, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06072612

Project: Every Child for Younger Patients With Cancer

Mengambil pesertaKajian pemerhatian
  • AdventHealth Orlando, Orlando
  • Arnold Palmer Hospital for Children, Orlando
  • Nemours Children's Hospital, Orlando
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT02402244

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • AdventHealth Celebration, Celebration · 17 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05592626

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Mengambil pesertaFasa 3
  • Orlando Health Cancer Institute, Orlando
  • Health Central, Ocoee · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06580314

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Mengambil pesertaFasa 1/2
  • Clermont Oncology Center, Clermont · 24 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT04198766

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Orlando Health UF Health Cancer Center, Orlando
Umur 12 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT05533697

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

Mengambil pesertaFasa 1
  • GSK Investigational Site, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Jun 2026 · NCT06431594

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Mengambil pesertaFasa 1/2
  • Orlando Health Cancer Institute, Orlando
Umur 18 hingga 70 · Semua jantina · Dikemas kini 11 Jun 2026 · NCT05361174

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Mengambil pesertaFasa 1
  • Research Site, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jun 2026 · NCT06835569

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Mengambil pesertaFasa 2
  • Clermont Oncology Center, Clermont · 24 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Jun 2026 · NCT06463665

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

Mengambil peserta
  • Orlando Health, Orlando
Umur 60 ke atas · Semua jantina · Dikemas kini 1 Mei 2026 · NCT05838638

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • AdventHealth Cancer Institute, Celebration · 17 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mac 2026 · NCT05948865

GEMINI-NSCLC: NSCLC Biomarker Study

Mengambil pesertaKajian pemerhatian
  • Clermont Oncology Center, Clermont · 24 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Feb 2026 · NCT05236114

Beat Childhood Cancer Specimen Banking and Data Registry

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Arnold Palmer Hospital for Children, Orlando
Semua umur · Semua jantina · Dikemas kini 3 Feb 2026 · NCT04715178

Caris Biorepository Research Protocol

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Advent Health, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Jan 2026 · NCT01499394

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

Mengambil pesertaKajian pemerhatian
  • AdventHealth Cancer Institute, Orlando
Umur 18 ke atas · Wanita · Dikemas kini 29 Jan 2025 · NCT04957511

Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer

Mengambil pesertaKajian pemerhatian
  • University of Central Florida, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Dis 2024 · NCT06148298

Kajian Kanser (semua jenis) di bandar lain

Kajian lain di Orlando

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.